Term Name: | 1-O-{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl}-N-hexacosanoylphytosphingosine |
---|---|
Synonyms: | (2S,3S,4R)-1-{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactopyranosyloxy}-2-hexacosanoylaminooctadecane-3,4-diol, N-((2S,3S,4R)-1-{4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyloxy}-3,4-dihydroxyoctadecan-2-yl)hexacosanamide, N-[(2S,3S,4R)-3,4-dihydroxy-1-({4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactopyranosyl}oxy)octadecan-2-yl]hexacosanamide, N-{(2S,3S,4R)-3,4-dihydroxy-1-[(4-O-{[4-(trifluoromethyl)phenyl]methyl}-alpha-D-galactopyranosyl)oxy]octadecan-2-yl}hexacosanamide |
Definition: | A glycophytoceramide having a 4-O-[4-(trifluoromethyl)benzyl]-alpha-D-galactosyl residue at the O-1 position and a hexacosanoyl group attached to the nitrogen. One of a series of an extensive set of 4"-O-alkylated alpha-GalCer analogues evaluated (PMID:30556652) as invariant natural killer T-cell (iNKT) antigens. |
Ontology: | ChEBI [CHEBI:145456] ( EBI ) |